International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2026
Verification and validation in canine cadaver of an MPI-integrable RF head coil for magnetic particle hyperthermia.
СтатьяПоддержка NIH: внешняя программаНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Carlton Hayden, Mattingly Eli, Mohtasebzadeh Abdul Rahman, Lad Yash Sharad, Pawar Shreeniket, Attaluri Anilchandra, Kraitchman Dara, Ivkov Robert, Goodwill Patrick
Аннотация
PURPOSE: Magnetic particle hyperthermia (MPH), the mild heating of solid tumors with magnetic nanoparticles, is an emerging treatment modality used as an adjuvant to therapies such as ionizing radiation. MPH can be paired with magnetic particle imaging (MPI) hardware to improve thermal treatment planning, spatially confined heating, and thermal dose delivery. In this work, we describe the design, verification, and validation of a radiofrequency (RF) head coil designed to integrate into a clinical MPI scanner.
METHODS: The RF coil was designed to accommodate an adult human head, provide a homogeneous (±10%) field along a 10 cm axial centerline, generate a peak magnetic flux density of 10 mT at 100 kHz, and be MPI compliant. Verification of the design consisted of a combination of magnetic field and nanoparticle heating measurements. To validate an MPI/MPH imaging and heating workflow, a canine cadaver was surgically prepared by implanting magnetic nanoparticles in the brain, followed by anatomical imaging, MPI, and heating with the head coil. To explore if the measured performance can be generalized to human treatment, we conducted a virtual MPH treatment of a human glioma.
RESULTS: Coil performance verification demonstrated RF fields as high as Bpeak=14 mT at 100.4 kHz, while achieving hyperthermic temperatures in tumor phantoms. The MPI scan of the canine cadaver head revealed differences in signal intensity between particle injection sites, which correlated with temperature increases measured during heating. Computational simulation of a human head showcased the feasibility of this system to treat gliomas.
CONCLUSIONS: We successfully constructed, verified, and validated an MPI-compatible RF head coil for combined MPI/MPH therapy.
METHODS: The RF coil was designed to accommodate an adult human head, provide a homogeneous (±10%) field along a 10 cm axial centerline, generate a peak magnetic flux density of 10 mT at 100 kHz, and be MPI compliant. Verification of the design consisted of a combination of magnetic field and nanoparticle heating measurements. To validate an MPI/MPH imaging and heating workflow, a canine cadaver was surgically prepared by implanting magnetic nanoparticles in the brain, followed by anatomical imaging, MPI, and heating with the head coil. To explore if the measured performance can be generalized to human treatment, we conducted a virtual MPH treatment of a human glioma.
RESULTS: Coil performance verification demonstrated RF fields as high as Bpeak=14 mT at 100.4 kHz, while achieving hyperthermic temperatures in tumor phantoms. The MPI scan of the canine cadaver head revealed differences in signal intensity between particle injection sites, which correlated with temperature increases measured during heating. Computational simulation of a human head showcased the feasibility of this system to treat gliomas.
CONCLUSIONS: We successfully constructed, verified, and validated an MPI-compatible RF head coil for combined MPI/MPH therapy.